| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000031763 |
| Receipt No. | R000036242 |
| Official scientific title of the study | Establishment of prevention method for head injury-related venous thromboembolism using anticoagulant. |
| Date of disclosure of the study information | 2018/06/01 |
| Last modified on | 2018/03/15 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Establishment of prevention method for head injury-related venous thromboembolism using anticoagulant. | |
| Title of the study (Brief title) | The new protocol of prophylaxis for head injury-related venous thromboembolism by anticoagulation. | |
| Region |
|
|
| Condition | |||
| Condition | head injury | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Head injury patients who are at high risk of the venous thromboembolism(VTE) undergo prophylactic anticoagulation with unfractionated heparin in addition to intermittent pneumatic compression. We compare incidence of VTE in those patients with historical control of patients treated with only intermittent pneumatic compression. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence of venous thromboembolism( VTE) during the hospitalization |
| Key secondary outcomes | Incidence of hemorrhagic adverse event |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | We perform intravenous administration of unfractionated heparin(10000 unit/day) for 14 days. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Head injury patients with 5 or more points of RAP score. | |||
| Key exclusion criteria | The patients that hemostasis is not obtained.
The patients with serious liver dysfunction or renal dysfunction. The patients with a history of Heparin-induced thrombocytopenia (HIT). The patients of the drug irritable diathesis such as allergies. The patients who may be pregnant and breast feeding. The patients whom a primary investigator judged to be inadequate for the study. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Tomohito Hirao |
| Organization | Nagasaki University Hospital |
| Division name | Emergency Medical Center |
| Address | 1-7-1, Sakamoto, Nagasaki City, Nagasaki |
| TEL | 095-819-7200 |
| thirao56513@gmail.com | |
| Public contact | |
| Name of contact person | Keita Iyama |
| Organization | Nagasaki University Hospital |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-7-1, Sakamoto, Nagasaki City, Nagasaki |
| TEL | 095-819-7200 |
| Homepage URL | |
| keita.i0829@gmail.com | |
| Sponsor | |
| Institute | Nagasaki University Hospital
Emergency Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | ZENKYOREN
(National Mutual Insurance Federation of Agricultural Cooperatives) |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 長崎大学病院(長崎県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036242 |